about
B cell receptor editing in tolerance and autoimmunityVkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strainsThe transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.Positive selection of natural poly-reactive B cells in the periphery occurs independent of heavy chain allelic inclusionB cell tolerance and positive selection in lupus.Dual-reactive B cells are autoreactive and highly enriched in the plasmablast and memory B cell subsets of autoimmune mice.Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasisDeletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.Prolactin Rescues Immature B-Cells from Apoptosis Induced by B-Cell Receptor Cross-Linking.RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetesYY1 plays an essential role at all stages of B-cell differentiation.The epigenetic landscape of B lymphocyte tolerance to self.Aberrant B cell selection and activation in systemic lupus erythematosus.Mechanisms of central tolerance for B cells.Trifluoperazine Inhibits Mesangial Cell Proliferation by Arresting Cell Cycle-Dependent MechanismsSelection of individual VH genes occurs at the pro-B to pre-B cell transition.The regulation of autoreactive B cells during innate immune responses.The immature B-cell subpopulation with low RAG1 expression is increased in the autoimmune New Zealand Black mouse.Trifluoperazine induces apoptosis through the upregulation of Bax/Bcl‑2 and downregulated phosphorylation of AKT in mesangial cells and improves renal function in lupus nephritis mice.
P2860
Q27692084-A50ADA75-7B95-4938-ADDC-C69360CC8627Q34267403-6F3A665D-11B4-46D0-B905-99B75B192371Q35490321-89FB3361-14C6-4300-AB03-9737F804FBA1Q35636916-3C35C873-7C28-48D7-90CF-54FE4274048FQ36093973-AB65A7DF-A95C-4759-B0E6-FEAC4196A3D6Q36278075-DF0C2029-AE2F-4116-88FE-F7167D2E6716Q36314636-2241E36B-955B-4237-A724-77A481312A87Q36811047-F0202A50-B63C-40E0-80C3-FA50D9C827BBQ36973924-8E71A593-9C62-47FD-B4CA-723AD27F9C18Q37019638-240C8EFB-A905-4365-8DC1-27D5D2425AF7Q37086666-BE02E20F-C261-4B76-A13F-3304CE21A093Q38107680-8A604576-C1E3-4BCA-ABC7-49E8954C1086Q38114501-464BE206-2112-46AD-9BB9-21291BE42A30Q39214736-A8792B23-140D-4240-A194-379D991FBAA8Q41113661-2C2C6BC6-2327-4526-926F-A3661936FACEQ42798565-A64AA146-F29E-4A01-B184-B0891CA8C818Q43100973-937CFF0E-AFCF-4F7E-8E73-3E138832BAA7Q50604667-83EB60F8-6129-4AD7-853F-FC46C22535C4Q54119830-2FDCF69F-B082-4B17-B987-CA27CB05757F
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reduced receptor editing in lupus-prone MRL/lpr mice
@ast
Reduced receptor editing in lupus-prone MRL/lpr mice
@en
type
label
Reduced receptor editing in lupus-prone MRL/lpr mice
@ast
Reduced receptor editing in lupus-prone MRL/lpr mice
@en
prefLabel
Reduced receptor editing in lupus-prone MRL/lpr mice
@ast
Reduced receptor editing in lupus-prone MRL/lpr mice
@en
P2093
P2860
P356
P1476
Reduced receptor editing in lupus-prone MRL/lpr mice
@en
P2093
Ann J Feeney
David Nemazee
Jennifer L Lamoureux
Lisa C Watson
Patrick Skog
P2860
P304
P356
10.1084/JEM.20071268
P407
P577
2007-10-29T00:00:00Z